Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

GSK signs oncology deal with UK biotech

May 18, 2009 Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics

GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …
News

Sanofi-Aventis signs deal with Japanese biotech

May 15, 2009 Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …
News

Kendle trims down as profits slump

May 15, 2009 Research and Development Kendle

Contract research organisation Kendle joined many of its peers in reporting a slump in demand for its clinical research services …
News

Boehringer signs diabetes and obesity deal

May 14, 2009 Research and Development, Sales and Marketing Boehringer

Boehringer Ingelheim has signed a deal with German biopharma firm DeveloGen to research and develop treatments for diabetes and obesity. …
News

Kennedy sets out views on NICE’s future

May 14, 2009 Research and Development NICE

Two stakeholder workshops which could shape NICE's future direction are to be held next week. Professor Sir Ian Kennedy has …
News

AstraZeneca buoyed as Brilinta tops Plavix in trial

May 13, 2009 Research and Development, Sales and Marketing AZ, Brillinta

AstraZeneca has been lifted by clinical results indicating its antiplatelet drug Brilinta outperformed Sanofi-Aventis/Bristol-Myers Squibb’s Plavix – currently the world’s …
News

UK a step closer to new swine flu vaccine

May 11, 2009 Research and Development NHS, h1n1

The first step towards producing a European prototype of a swine flu vaccine has been achieved by the UK's Health …
News

GSK claims superiority for Cervarix in head-to-head trial

May 11, 2009 Research and Development, Sales and Marketing GSK, vaccines

GlaxoSmithKline says a new study shows its cervical cancer vaccine Cervarix induces a higher immune response compared to rival Gardasil. …
News

Cmed and Tessella join forces on adaptive trials

May 11, 2009 Research and Development Cmed, digi

UK contract research organisation Cmed Research has bolstered its ability to carry out adaptive clinical trials on behalf of clients …
News

Pharma must go further with its collaborations

May 8, 2009 Research and Development, Sales and Marketing pwC, strategy

Pharma companies will soon have to start collaborating with companies outside the healthcare sector.The global economic situation will make this …
News

Servier signs drug discovery deal with Vernalis

May 7, 2009 Research and Development, Sales and Marketing Servier, Vernalis

Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …
News

NICE rejects Nexavar for liver cancer

May 7, 2009 Research and Development, Sales and Marketing Bayer, NICE, Nexavar

NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …
News

Novo Nordisk plans summer launches for new diabetes drug

May 7, 2009 Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes

Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …
News

NHS should be ‘jewel in the crown’ for UK biotech

May 7, 2009 Research and Development NICE

The NHS could be the 'jewel in the crown' of UK medical research, if it would only assist in clinical …
News

Bayer Schering’s contraceptive patch enters phase III

May 5, 2009 Research and Development, Sales and Marketing Bayer, sexual health

Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025